Suchergebnisse - "Barlow, William E"

PubPharm (5)

1

Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226

enthalten in: Pharmacogenomics | 2023

von Rutherford, D. | Medley, S. | Henderson, N. | +15

2

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

enthalten in: The New England journal of medicine | 2021

von Kalinsky, K. | Barlow, W. | Gralow, J. | +31

CommentIn: Nat Rev Clin Oncol. 2022 Feb;19(2):72. - PMID 34912052

3

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Paoletti, C. | Barlow, W. | Cobain, E. | +11

4

Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer

enthalten in: JAMA oncology | 2016

von Hershman, D. | Unger, J. | Wright, J. | +7

CommentIn: JAMA Oncol. 2016 Apr;2(4):461-2. - PMID 26720183

5

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2009

von Albain, K. | Barlow, W. | Ravdin, P. | +18

CommentIn: Lancet. 2009 Dec 19;374(9707):2029-2030. - PMID 20004965

1
[1]